Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

ClinicalTrials.gov ID: NCT05908084

Public ClinicalTrials.gov record NCT05908084. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized Study to Compare the Efficacy and Safety of the Humacyte Acellular Tissue Engineered Vessel (ATEV) With That of an Autogenous Arteriovenous Fistula (AVF) in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infections between the ATEV and AVF groups over 12 months in patients with end-stage renal disease (ESRD) needing hemodialysis (HD). Participants will be stratified by location of the vascular access (forearm versus upper arm) and by type of AVF creation procedure planned by the surgeon at randomization (1-stage AVF versus 2-stage AVF). The comparator is an upper extremity arterio-venous fistula (AVF) for HD access surgically created per the institution's Standard of Care (SoC).

Study identification

NCT ID
NCT05908084
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Humacyte, Inc.
Industry
Enrollment
121 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 6, 2023
Primary completion
May 31, 2027
Completion
May 31, 2028
Last update posted
Jun 25, 2026

2023 – 2028

United States locations

U.S. sites
32
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Honor Health Scottsdale Shea Medical Center Scottsdale Arizona 85260
El Centro Regional Medical Center El Centro California 92243
Jacob's Medical Center at UC San Diego Health La Jolla California 92037
Denver Health and Hospital Authority Denver Colorado 80204
Yale New Haven Hospital New Haven Connecticut 06519
Access Research Institute Brooksville Florida 34613
University of FL Health Heart and Vascular Hospital Gainesville Florida 32608
Mayo Clinic Florida Jacksonville Florida 32224
American Access Care of Miami, LLC Miami Florida 33156
USF Health South Tampa Tampa Florida 33606
Georgia Nephrology Atlanta Georgia 30046
Grady Memorial Hospital Atlanta Georgia 30303
IU Health Bloomington Hospital Bloomington Indiana 47408
John Hopkins University School of Medicine Baltimore Maryland 21287
Brigham and Women's Hospital Boston Massachusetts 02115
Boston Medical Center Boston Massachusetts 02118
University of Michigan Ann Arbor Michigan 48109
Rutgers University_Medical Newark New Jersey 07103
St.Joseph's University Medical Center Paterson New Jersey 07503
Capital Health Medical Center- Hopewell Pennington New Jersey 08534
New York-Presbyterian Queens_The Lang Center for Research & Education Flushing New York 11355
Ambulatory Care Pavilion Westchester Medical Center Valhalla New York 10595
Surgical Specialists of Charlotte Charlotte North Carolina 28207
Duke Regional Hospital Durham North Carolina 27704
Wake Forest University School of Medicine_Atrium Health Wake Forest Baptist Winston-Salem North Carolina 27157
Temple University Philadelphia Pennsylvania 19140
University of Tennessee Medical Center Knoxville Tennessee 37920
Dell Seton Medical Center at The University of Texas at Austin Austin Texas 78701
Dr. Ruben Villa__Nephrology Lubbock Texas 79407
Cataract & Surgery Center Lubbock Lubbock Texas 79410
San Antonio Vascular and Endovascular Clinic PLLC San Antonio Texas 78221
The San Antonio Vascular and Endovascular Clinic San Antonio Texas 78221

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05908084, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05908084 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →